Vivid Dx is a startup based in the United Kingdom, 1 tracked investor.
Based in the United Kingdom, Vivid Dx is a startup. Brouky records 1 investor associated with the company.
Vivid Dx is developing a novel diagnostic platform for the early detection of cancer using liquid biopsy and circulating tumour DNA (ctDNA). The company aims to provide non-invasive and highly accurate cancer screening.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.